Ribonuclease resistant RNA preparation and utilization

Details Ribonuclease resistant RNA preparation and utilization Ribonuclease resistant RNA preparation and utilization

2006-04-25

2006-04-25

McKelvey, Terry (Department: 1636)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

C435S006120, C435S235100, C536S023100, C536S023500, C536S023520

Reexamination Certificate

active

07033749

ABSTRACT:
The present invention relates to nuclease resistant nucleic acids in general and ribonuclease resistant RNAs in particular. Methods of making and using such nucleic acids are disclosed.

REFERENCES:
patent: 5091309 (1992-02-01), Schlesinger et al.
patent: 5443969 (1995-08-01), Wilson et al.
patent: 5500360 (1996-03-01), Ahlquist et al.
patent: 5578473 (1996-11-01), Palese et al.
patent: 5589367 (1996-12-01), Donson et al.
patent: 5602242 (1997-02-01), Ahlquist et al.
patent: 5614413 (1997-03-01), Morrow
patent: 5618699 (1997-04-01), Hamamoto et al.
patent: 5622705 (1997-04-01), Morrow
patent: 5627060 (1997-05-01), Ahlquist et al.
patent: 5677124 (1997-10-01), DuBois et al.
patent: 5716821 (1998-02-01), Wertz et al.
patent: 5736388 (1998-04-01), Chada et al.
patent: 5739026 (1998-04-01), Garoff et al.
patent: 5766840 (1998-06-01), Kim et al.
patent: 5919625 (1999-07-01), DuBois et al.
patent: 5939262 (1999-08-01), Pasloske et al.
patent: 6214982 (2001-04-01), Pasloske et al.
patent: 6399307 (2002-06-01), Pasloske et al.
patent: 6613749 (2003-09-01), Forstova et al.
patent: 0278667 (1988-08-01), None
patent: 0 525 882 (1993-02-01), None
patent: 0278667 (1994-07-01), None
patent: WO 87/06261 (1987-10-01), None
patent: WO 93/03161 (1993-02-01), None
patent: WO 94/28171 (1994-12-01), None
patent: WO 95/02067 (1995-01-01), None
patent: WO 95/14109 (1995-05-01), None
patent: WO 95/15974 (1995-06-01), None
patent: WO 95/34684 (1995-12-01), None
patent: WO 00/63440 (2000-10-01), None
Lim et al., Tranlational repression and specific RNA binding by the coat protein of the Pseudomonas phage PP7. The Journal of Biological Chemistry, vol. 276, No. 25, pp. 22507-22513, 2001.
Wu et al., A comparison of two phage coat protein-RNA interactions. Nucleic Acids Research, vol. 16, No. 11, pp. 5055-5066, 1988.
Beckett et al., Roles of operator and non-operator RNA sequences in bacteriophage R17 capsid assembly. Journal of Molecular Biology, vol. 204, pp. 939-947, 1988.
GenBank Accession No. L09130, 1982.
Rao et al., DNA packaging of bacteriophage T4 proheads in vitro: Evidence that prohead expansion is not coupled to DNA packaging. Journal of Molecular Biology, vol. 185, No. 3, pp. 565-578, 1985.
Wickner et al., Membrane-associated assembly of M13 phage in extracts of virus-infectedEscherichia coli. PNAS, USA, vol. 74, No. 2, pp. 505-509, 1977.
Gottlieb et al., In vitro packaging of the bacteriophage phi6 ssRNA genomic precursors. Virology, vol. 181, pp. 589-594, 1991.
Turner et al., The tobacco mosaic virus assembly origin RNA. Functional characteristics defined by directed mutagenesis. Journal of Molecular Biology, vol. 203, No. 3, pp. 531-547, 1988.
Bradley, Ultrastructure of bacteriophages and bacteriocins, Bacteriological Reviews, vol. 31, No. 4, pp. 230-314, 1967.
Conry et al., “Characterization of a Messenger RNA Polynucleotide Vaccine Vector,”Cancer Research,55(7):1397-1400, Apr. 1995.
Dwarki, Malone and Verma, “Cationic Liposome-Mediated RNA Transfection,”Methods in Enzymology,217:644-654, 1993.
Heidenreich, Pieken and Eckstein, “Chemically Modified RNA: Approaches and Applications,”FASEB J., 7:90-96, 1993.
Natarajan et al., “An Internally Controlled Virion PCR for the Measurement of HIV-1 RNA in Plasma,”PCR Methods Appl.,3(6):346-350, 1994.
Peabody, “The RNA binding site of bacteriophage MS2 coat protein,”The EMBO Journal12(2):595-600, 1993.
Reischl and Kochanowski., “Quantitative PCR: A Survey of the Present Technology,”Molecular Biotechnology,3:55-71, 1995.
Stockley et al., “Molecular Mechanism of RNA Phage Morphogenesis,”Int. J. Biochem., 26(10/11)1249-1260, 1994.
Stonehouse and Stockley, “Effects of Amino Acid Substitution on the Thermal Stability of MS2 Capsids Lacking Genomic RNA,”FEBS, 334(3):355-389, Nov. 1993.
Argetsinger and Gussin, “Intact Ribonucleic Acid from Defective Particles of Bacteriophage R17,”J Mol Biol, 21:421-434, 1966.
Aslanzadeh et al., “Evaluation of PCR and Nested PCR for Laboratory Diagnosis of Hepatitis C Virus Infection,”Mol Cell Probes, 10:173-178, 1996.
Barlow et al., “Analysis and Genotyping of PCR Products of the Amplicor HIV-1 Kit,”J Virological Methods, 52:65-74, 1995.
Collins et al., “Preparation and Characterization of RNA Standards for Use in Quantitative Branched DNA Hybridization Assays,”Analytical Biochemistry, 226:120-129, 1995.
Dolja et al., “Phylogeny of Capsid Proteins of Rod-Shaped and Filamentous RNA Plant Viruses: Two Families with Distinct Patterns of Sequence and Probably Structure Conservation,”Virology, 184:79-86, 1991.
Duda et al., “Expression of Plasmid-Encoded Structural Proteins Permits Engineering of Bacteriophage T4 Assembly,”Virology, 179:728-737, 1990.
Durham, “Structures and Roles of the Polymorphic Forms of Tobacco Mosaic Virus Protein,”J. Mol. Biol., 67:289-305, 1972.
Durham, “The Cause of Irreversible Polymerisation of Tobacco Mosaic Virus Protein,”FEBS Letters, 25(1):147-152, 1972.
Fritsch et al., “Specificity of TMV RNA Encapsidation: in vitro Coating of Heterologous RNA by TMV Protein,”Virology, 56:33-45, 1973.
Gallie et al., “In Vivo Uncoating and Efficient Expression of Foreign mRNAs Packaged in TMV-Like Particles,”Science, 236:1122-1124, 1987.
Gallie et al., “The Effect of Multiple Dispersed Copies of the Origin-of-Assembly Sequence From TMV RNA on the Morphology of Pseudovirus Particles Assembled In Vitro,”Virology, 158:473-476, 1987.
Gal-On et al., “Nucleotide Sequence of the Zucchini Yellow Mosaic Virus Capsid-Encoding Gene and its Expression inEscherichia coli,” Gene87:273-277, 1990.
Gibbs, “Tobamovirus Group,”C.M.I./A.A.B. Descriptions of Plant Viruses, No. 184, Commonwealth Bureaux and the Association of Applied Biologists, Sep. 1977.
Goelet et al., “Nucleotide Sequence of Tobacco Mosaic Virus RNA,”Proc. Natl. Acad. Sci. USA, 79:5818-5922, 1982.
Golmohammadi et al., “The Refined Structure of Bacteriophage MS2 at 2·8 Å Resolution,”J Mol Biol, 234:620-639, 1993.
Goulden et al., “Structure of Tobraviral Particles: A Model Suggested From Sequence Conservation in Tobraviral and Tobamoviral Coat Proteins,”J. Mol. Biol., 227:1-8, 1992.
Guilley et al., “Observations Concerning the Sequence of Two Additional Specifically Encapsidated RNA Fragments Originating From the Tobacco-Mosaic-Virus Coat-Protein Cistron,”Eur. J. Biochem., 54:145-153, 1975.
Guilley et al., “Sequence of a Specifically Encapsidated RNA Fragment Originating From the Tobacco-Mosaic-Virus Coat-Protein Cistron,”Eur. J. Biochem., 54:135-144, 1975.
Guo et al., “sRNA of Phage φ29 ofBacillus subtilisMediates DNA Packaging of φ29 Proheads Assembled inEscherichia coli,” Virology, 185:395-400, 1991.
Harrison, “Pea Early-Browning Virus,”C.M.I./A.A. B. Descriptions of Plant Viruses, No. 120, Commonwealth Bureaux and the Association of Applied Biologists, Jul. 1973.
Harrison, “Tobacco Rattle Virus,”C.M.I./A.A.B. Descriptions of Plant Viruses, No. 12, Commonwealth Bureaux and the Association of Applied Biologists, Jun. 1970.
Haynes et al., “Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein,”Biotechnology, 4:637-641, 1986.
Heisenberg, “Formation of Defective Bacteriophage Particles by frAmberMutants,”J. Mol. Biol., 17:136-144, 1966.
Hughes and Andrew, “Creation of Deletion, Insertion and Substitution Mutations Using a Single Pair of Primers and PCR,”Biotechniques, 20(2):188-196, 1996.
Hwang et al., “Expression of Tobacco Mosaic Virus Coat Protein and Assembly of Pseudovirus Particles inEscherichia coli,” Proc. Natl. Acad. Sci. USA, 91:9067-9071, 1994.
International Search Report dated Oct. 21, 199

Affiliated with

Also associated with

Rating

Ribonuclease resistant RNA preparation and utilization does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ribonuclease resistant RNA preparation and utilization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribonuclease resistant RNA preparation and utilization will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3561303